aXichem and its partner Chr. Olesen kick of first step in the pre-launch of aXiphen in the feed market
January 25, 2023
aXichem and its partner Chr. Olesen kick of first step in the pre-launch of aXiphen in the feed market

aXichem AB (publ), a developer of natural analogue industrial compounds, announces that Chr. Olesen a leading distributor of feed ingredients in Europe and the Americas, has added aXichem’s proprietary ingredient aXiphen® to their official product portfolio. The inclusion of aXiphen in the product line is the first step in a pre-launch marketing program and further confirms Chr. Olesen's commitment to providing innovative and high-quality feed solutions to the market.

“We are looking forward to the coming feed additive approval in Europe and the product registration in South America for aXiphen, and to fully market and sell this innovative ingredient to leading feed producers,” says Christian D. Olesen, Head of Business Development Feed at Chr. Olesen. “I’m thrilled to be overseeing the market introduction of aXiphen, and work together with my experienced international team as well as with the product experts at aXichem. “, says Christian D. Olesen, who represents the 5th generation at the family-owned Chr. Olesen Group.

“We are pleased that aXichem has received the first comments from the European Food Safety Authority (EFSA) on their feed additive application and we are confident that they are approaching an approval from EFSA. aXichem has been working closely with the regulatory team to ensure that all relevant data is submitted to EFSA in the coming months. I’m confident that our experienced team will take lead of a successful launch of aXiphen”, says Mads C. Olesen, owner and CEO of Chr. Olesen Group.

"It is great to start working with the pre-launch of aXiphen and to plan the market introduction together with the inspiring and knowledgeable team at Chr. Olesen. I am convinced that aXiphen’s value adding qualities will be well-received by the poultry feed producers," says Torsten Helsing, CEO of aXichem.

About phenylcapsaicin and aXiphen
The health benefits of chili, with its active ingredient capsaicin have been known for centuries. aXichem’s proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, bridged by a triple bond. The result is an innovative natural analogue capsaicin with high purity, where the pungency is greatly reduced.
Studies have proven the effectiveness of aXiphen® as an ingredient in poultry feed.

A study on on-floor salmonella prevalence, following the inclusion of 15 ppm phenylcapsaicin in a regular starter diet, was carried out in a full-scale commercial broiler production trial under farming conditions. The study comprised 18 broiler farms with 57 broiler chicken houses and 1 659 540 broiler chickens. The study concluded that under the conditions of the study, the inclusion of 15 ppm phenylcapsaicin in broiler chicken feed statistically significantly reduced both the number of farms and the number of houses with salmonella-positive floor boot swabs.

About Chr. Olesen Group

Chr. Olesen is family-owned company established in 1885 in Denmark.

The Company has decades of experience in distributing ingredients to the Feed, Food and Pharma industries all over the world. Chr. Olesen provides product quality and safety, with a knowledge of prices according to market conditions and trends – as well as efficient storage, a global delivery service and timely transportation. The business is built on long term relationships and strategic partnerships with customers and suppliers. More about Chr. Olesen at

The information was submitted, through the care of the contact person, for publication on 25 January 2023, at 08:30 AM CEST